CLXClorox
Is the business good?
4 of 9 health tests passed. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is CLX?
Clorox keeps 8.7% of every revenue dollar as profit after everything, against 6.1% for the median Household & Personal Products name.
Net margin · Household & Personal Products median 6.1% · 12 months to Q4 2026
- R&D as % of revenue
- 1.7%
R&D as % of revenue
- Gross margin
- 42%
Gross margin
Details›
- Gross margin12 months to Q4 2026
- 42%
- Net margin12 months to Q4 2026
- 8.7%
- Free cash flow margin
- 6.0%
- R&D as % of revenue
- 1.7%
- Revenue, trailing twelve months
- $6.72B
- Free cash flow, trailing twelve months
- $405M
- Net income, trailing twelve months
- $587M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from CLX and who it buys from, as the companies report it.
- WMTWalmart26%
Share of revenue · FY2026 10-K
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; CLX’s own figures are from its FY2026 10-K. Smaller customers and suppliers go unreported.
Household & Personal Products
The closest names by size in the same industry